References
- Blauvelt A, de Bruin-Weller M, Gooderham M, et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet. 2017;389(10086):2287–2303.doi:10.1016/S0140-6736(17)31191-1.
- Simpson EL, Bieber T, Guttman-Yassky E, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375(24):2335–2348.doi:10.1056/NEJMoa1610020.
- Thyssen JP, Toft PB, Halling-Overgaard AS, Gislason GH, Skov L, Egeberg A. Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis. J Am Acad Dermatol. 2017;77(2):280–286.e1. doi:10.1016/j.jaad.2017.03.003.
- de Bruin-Weller M, Thaçi D, Smith CH, et al. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t. Br J Dermatol. 2018;178(5):1083–1101.doi:10.1111/bjd.16156.
- Mennini M, Dahdah L, Fiocchi A, Simpson EL. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2017;376(11):1090–1091. doi:10.1056/NEJMc1700366.
- Akova YA, Rodriguez A, Foster SC. Atopic keratoconjunctivitis. Ocul Immuol Inflamm. 1994;2(3):125–144. doi:10.3109/09273949409057069.
- Steven P, Gebert A. Conjunctiva-associated lymphoid tissue- Current knowledge, animal models and experimental prospects. Ophthalmic Res. 2009;42(1):2–8. doi:10.1159/000219678.
- Knop E. Conjunctiva Immune Surveillance. In: Besharse J, Dana R, Dartt D, eds. Encyclopedia of Eye. Vol. 1. 1st ed. Oxford, UK: Academic Press;2010:356–368.
- Azari AA, Barney NP. Conjunctivitis: A systemic review of diagnosis and treatment. JAMA. 2013 October;310(16):1721–1729. doi:10.1001/jama.2013.280318.
- Wollenberg A, Ariens L, Thurau S, van Luijk C, Seegräber M, de Bruin-Weller M. Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment. J Allergy Clin Immunol Pract. 2018;5–8. doi:10.1016/j.jaip.2018.01.034.
- Kolomeyer A, Nayak N, Ragam A, et al. Topical Cyclosporine A 1% for the Treatment of Chronic Follicular Conjunctivitis. Eye Contact Lens. 2015;41(4):210–213.doi:10.1097/ICL.000000.